Candesartan HCT Zentiva 16/12.5mg, Tabletten - 30 Swissmedic Key 62321015 Registration Holder Helvepharm AG Name Candesartan HCT Zentiva 16/12.5mg, Tabletten Date of registration 30.01.2012 Original/Generic Generic Introduction of Sequence 30.01.2012 ATC-Classification Candesartan and Diuretics (C09DA06) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 02.07.20. Show package size 30 Index Therapeuticus (Swissmedic) 02.07.20. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 10.19 Limitation No Deductible 10 % Consumer price 27.45 Feedback FB GTIN 7680623210159 Medication Code Synthetika Pharmacode Disponibility
Composition candesartanum cilexetilum 16 mg, hydrochlorothiazidum 12.5 mg, maydis amylum, lactosum monohydricum 109.3 mg, triethylis citras, hydroxypropylcellulosum, carmellosum natricum conexum 4 mg corresp. magnesii stearas, pro compresso, natrium 0.36 mg. Packungsbestandteile Galenic Form Tablets Active Agent Dose Candesartanum Cilexetil 16 mg Hydrochlorothiazide 12.5 mg
BAG: Active Agent Dose Candesartanum Cilexetil 16 mg Hydrochlorothiazide 12.5 mg
Inactive agents Dose Carmellosum Natricum Conexum 4 mg Hydroxypropylcellulosum Lactose Monohydrate 109.3 mg Maydis Amylum Sodium 0.36 mg Pro Compresso Triethylis Citras
Source Data was imported : 06.07.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
